All Episodes
Base to Base Biotech — 67 episodes
Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier
Base to Base biotech podcast 66: The future of clinical trials and breakthroughs in molecular testing
Base to Base biotech podcast 65: Giving medicine a genetic camouflage
Base to Base biotech podcast 64: Solving logistics challenges
Base to Base biotech podcast 63: Cell and gene therapy logistics, and turning back the Parkinson’s clock
Base to Base biotech podcast 62: A new approach to strokes
Base to Base biotech podcast 61: Making tumours visible, and taking on tough challenges
Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size
Base to Base biotech podcast 59: DIA helping biotech thrive, and Gorlin syndrome
Base to Base biotech podcast 58: Congenital myotonic dystrophy
Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
Base to Base biotech podcast 56: GRIN genes and relapsing MS
Base to Base biotech podcast 55: Beating transplant challenges and a circular supply chain
Base to Base biotech podcast 54: Parkinson’s disease and peptides
Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes
Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space
Base to Base biotech podcast 51: Ovarian cancer, blue crayfish, and stopping brittle bone disease
Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and drug delivery
Base to Base biotech podcast 49: Gene therapy for kidney disease, and using AI to transform diagnostics
Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases
Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy
Base to Base biotech podcast 46: Endometriosis and closing care gaps
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immun0-oncology company collaborate
Base to Base biotech podcast 43: Natural killer cell therapy and attacking tumours
Base to Base biotech podcast 42: Treating blood cancers, Scottish Brain Sciences and One BioHub Aberdeen, and is speech the new blood?
Base to Base biotech podcast 41: Eyes, mitochondria and a growing hub
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Base to Base biotech podcast 39: Gene therapy for eye problems, GAIA, and separation science
Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells
Base to Base biotech podcast 37: Life Sciences in Flanders, AI and drug discovery, and healthcare investment
Base to Base biotech podcast 36: Life science in Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
Base to Base biotech podcast 35: Gothenburg Tech Week, osteoarthritis and respiratory virus infections
Base to Base biotech podcast 34: World Immunization Day and infertility
Base to Base biotech podcast 33: Pain relief, fungi and psychedelics
Base to Base biotech podcast 32: Multi-omics data and protein degradation
Base to Base biotech podcast 31: Exhilarating enzymes and super socks
Base to Base biotech podcast 30: Life sciences in Lithuania
Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms
Base to Base biotech podcast 26: Stand Up To Cancer Day
Base to Base biotech podcast 25: Molecular glue degradation
Base to Base biotech podcast 24: Dissecting the US cuts to mRNA vaccine projects and Herantis takes on Parkinson’s disease
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies
Base to Base biotech podcast 21: Elix drug discovery platform, and CytoAgents on CAR-T, CRS and the FDA
Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles
Base to Base biotech podcast 19: Nipro on dialysis and LenioBio on cell-free protein synthesis
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Base to Base biotech podcast 17: Silico nanoparticle gene delivery, and diagnosing urinary tract infections
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
Base to Base biotech podcast 15: Bio-convergence and cancer vaccines
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
Base to Base biotech podcast 7: The DSCSA deadline and MoonLake's Nanobody
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics